WuXi AppTec Co Ltd
F:WX8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
W
|
WuXi AppTec Co Ltd
F:WX8
|
CN |
|
C
|
China High Speed Transmission Equipment Group Co Ltd
SWB:BGR
|
KY |
|
A
|
Atea ASA
XMUN:MKL
|
NO |
|
J
|
Jardine Cycle & Carriage Ltd
XMUN:CYC
|
SG |
Intrinsic Value
Is WX8 undervalued or overvalued?
See the intrinsic value estimate for 
WuXi AppTec Co Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
WX8 looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with WX8’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What WuXi AppTec Does
WuXi AppTec is a contract research, development, and manufacturing partner for drugmakers. It helps pharmaceutical and biotech companies discover new compounds, test them in labs and animals, run preclinical work, and support the move into clinical development. It also helps make drug substances and finished medicines for customers that do not want to build every step of that process in-house.
- Headquarters
- China CN
- Employees
- 33 834
- IPO date
- May 8, 2018
WuXi AppTec has a narrow economic moat
Moving an established drug project to another supplier can mean costly transfers, extra testing and delays, giving customers a practical reason to stay with WuXi AppTec. Its protection is strongest when it has developed the manufacturing process and supplies drugs for advanced trials or commercial sale.
Read the full moat analysis
Revenue & Expenses Breakdown
WuXi AppTec Co Ltd
Earnings Waterfall
WuXi AppTec Co Ltd
The intrinsic value for WuXi AppTec Co Ltd (WX8) under the Base Case is hidden EUR.
Compared with the current market price of 21.105 EUR, the stock appears hidden.